PharmaResearch Awards Top 20 Rejuran Clinics in Indonesia

Strengthening Global Medical Aesthetic Market Expansion

PharmaResearch (CEO Jihoon Sohn) announced that it has recognized the Top 20 Rejuran clinics in Indonesia for 2024 with appreciation plaques.

This initiative was undertaken to express gratitude to key partner clinics in the Indonesian market and to further solidify long-term partnerships.

The clinics selected for the award have significantly contributed to expanding Rejuran’s market presence and brand recognition in Indonesia. The selection was based on factors such as collaboration with the brand and market influence.

A PharmaResearch official stated, "Rejuran has been widely recognized for its efficacy across multiple countries. PharmaResearch remains committed to strengthening collaboration with partner clinics globally while expanding its Key Opinion Leader (KOL) network."

 About PharmaResearch

 PharmaResearch is a pioneering biopharmaceutical company dedicated to enhancing the quality of life for humanity through regenerative medicine. With a diverse portfolio encompassing medicines, medical devices, cosmetics, and supplements, PharmaResearch focuses on leveraging its core ingredients, DOT™ PDRN and DOT ™PN. These active tissue regenerative substances are powered by DOT™, an exclusive DNA fragments optimization technology safeguarded by a suite of patents. PharmaResearch is in Seongnam, South Korea, and its US subsidiary, PharmaResarch USA is in Costa Mesa, Califrornia, US.